MicroRNA-98 regulates hepatic cholesterol metabolism via targeting sterol regulatory element-binding protein 2
Creators
- 1. Department of Breast and Thyroid Surgery, Shandong Provincial Hospital Affiliated to Shandong University, Jinan, Shandong Province, 250021 (China)
- 2. The Second Department of Surgery, Hospital of Traditional Chinese Medicine, Lingcheng, Dezhou, Shandong Province, 253500 (China)
- 3. Department of General Surgery, Dongchangfu People's Hospital, Liaocheng, Shandong Province, 252000 (China)
- 4. The First Department of General Surgery, Pingyuan People's Hospital, Pingyuan, Dezhou, Shandong Province, 253100 (China)
- 5. The Second Department of General Surgery, Pingyuan People's Hospital, Pingyuan, Dezhou, Shandong Province, 253100 (China)
- 6. Department of General Surgery, Laoling People's Hospital, Laoling, Dezhou, Shandong Province, 253600 (China)
- 7. Department of General Surgery, Yucheng People's Hospital, Yucheng, Dezhou, Shandong Province, 251200 (China)
- 8. School of Medicine, Shandong University, Jinan, Shandong Province, 250012 (China)
Description
Highlights: • The expression of miR-98 decreased while the expression of SREBP-2 increased in hypercholesterolemic patients. • SREBP-2 is a direct target gene of miR-98. • The effect of miR-98 on cholesterol metabolism is mediated by SREBP-2. • Overexpression of miR-98 reduced cholesterol level in vitro and in vivo. Hypercholesterolemia is an important risk factor for coronary heart disease. Although a lot of research has been conducted, the regulation of cholesterol metabolism is still largely unknown. Some miRNAs have been found to play critical role in the cholesterol metabolism. MiR-98 is a miRNA whose function has been reported mainly in tumorigenesis. In this study, we elucidate a novel role of miR-98 in cholesterol metabolism. We found that the expression of miR-98 was decreased significantly in hypercholesterolemic patients compared with healthy control subjects. Furthermore, we identified that SREBP-2, an important transcriptional factor in cholesterol metabolism, was a direct target of miR-98. Overexpression of miR-98 significantly repressed the 3′-UTR reporter activities of SREBP-2 in a dose-dependent manner in HepG2 cells, while the effect of miR-98 was blocked when the binding site of miR-98 within the SREBP-2 3′-UTR was mutated. And overexpression of miR-98 reduced both the mRNA and protein levels of HMGCR and LDLR significantly in vitro, which are two target genes of SREBP-2. Furthermore, MiR-98 overexpression reduced the intracellular total cholesterol levels dramatically. Moreover, we overexpressed the miR-98 by lentiviral tail vein injection in vivo. Compared with the control mice, the miR-98 overexpression mice showed lower serum cholesterol level and decreased SREBP-2, HMGCR as well as LDLR expression. Our data confirmed that reduced expression of miR-98 potentially contributes to disturbance of cholesterol metabolism. MiR-98 might be a novel therapeutic target to hypercholesterolemia.
Availability note (English)
Available from http://dx.doi.org/10.1016/j.bbrc.2018.08.205Additional details
Identifiers
- DOI
- 10.1016/j.bbrc.2018.08.205;
- PII
- S0006291X18319107;
Publishing Information
- Journal Title
- Biochemical and Biophysical Research Communications
- Journal Volume
- 504
- Journal Issue
- 2
- Journal Page Range
- p. 422-426
- ISSN
- 0006-291X
- CODEN
- BBRCA9
INIS
- Country of Publication
- United States
- Country of Input or Organization
- International Atomic Energy Agency (IAEA)
- INIS RN
- 53020024
- Subject category
- S60: APPLIED LIFE SCIENCES;
- Descriptors DEI
- CARDIOVASCULAR DISEASES; CHOLESTEROL; LIVER; MESSENGER-RNA; MICE; OXIDOREDUCTASES; VEINS
- Descriptors DEC
- ANIMALS; BLOOD VESSELS; BODY; CARDIOVASCULAR SYSTEM; DIGESTIVE SYSTEM; DISEASES; ENZYMES; GLANDS; HYDROXY COMPOUNDS; MAMMALS; NUCLEIC ACIDS; ORGANIC COMPOUNDS; ORGANS; PROTEINS; RNA; RODENTS; STEROIDS; STEROLS; VERTEBRATES
Optional Information
- Copyright
- Copyright (c) 2018 Elsevier Inc. All rights reserved.